<p>This podcast is about a long term follow up to the START trial which originally showed that starting<br>
antiretroviral therapy even at high CD4 counts (above 500) was better than waiting until CD4 counts drop to<br>

What We Know About Xylazine

Conversations with Clinical Education Initiative (CEI) features clinical experts in HIV Primary Care and Prevention, Sexual Health, Hepatitis C and Drug User Health. Our episodes feature CEI clinicians’ experience and insight on the current health issues, alongside the latest news and guidelines on our areas of expertise.

This podcast is produced by the CEI, a New York State Department of Health AIDS Institute program.